Recent bladder cancer studies have shown that genetic mutations in bladder epithelial cells frequently occur in FGFR3, PIK3CA, and RAS (all associated with RAS signaling networks) (Bockorny et al., 2018; Tsujino et al., 2019). The gene discussed is FGFR3; the disease is urinary bladder cancer.